Jason Westin

Jason Westin

UNVERIFIED PROFILE

Are you Jason Westin?   Register this Author

Register author
Jason Westin

Jason Westin

Publications by authors named "Jason Westin"

Are you Jason Westin?   Register this Author

93Publications

3580Reads

50Profile Views

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas.

Authors:
Paolo Strati Loretta J Nastoupil Richard E Davis Luis E Fayad Nathan Fowler Fredrick B Hagemeister Larry Kwak Yasuhiro Oki Michael Wang Jason Westin Charnelle E Ruben Emily T Wesson Richard Piekarz Michelle A Fanale Hun Ju Lee

Haematologica 2020 Jan 9;105(1):e26-e28. Epub 2019 May 9.

Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3324/haematol.2019.220012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939506PMC
January 2020

Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function.

Authors:
Jillian R Gunther Chanhyun Park Bouthaina S Dabaja Sarah A Milgrom Ruben J Cruz Chamorro L Jeffrey Medeiros Joseph D Khoury Naveen Garg Behrang Amini Raphael Steiner Ranjit Nair Paolo Strati Jason R Westin Hun Ju Lee Nathan Fowler Loretta Nastoupil Sattva S Neelapu Chelsea C Pinnix

Leuk Lymphoma 2020 Jan 2;61(1):171-175. Epub 2019 Aug 2.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/10428194.2019.1644333DOI Listing
January 2020

Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience.

Authors:
Vishwanath Sathyanarayanan Amir Issa Raisa Pinto Luis E Fayad Sanam Loghavi Fredrick Hagemeister Jason R Westin

Clin Lymphoma Myeloma Leuk 2019 Nov 4;19(11):709-714. Epub 2019 Jul 4.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2019.06.013DOI Listing
November 2019

A rare case of methotrexate and primaquine co-administration in a mantle cell lymphoma patient.

Authors:
Alan L Myers Jitesh D Kawedia Ahmed Nader Jason R Westin Brandon R Shank

J Clin Pharm Ther 2019 Oct 20;44(5):800-804. Epub 2019 May 20.

Department of Pharmacy Clinical Services, The University of Texas M.D. Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/jcpt.12849DOI Listing
October 2019

Gastrointestinal Adverse Events Observed After Chimeric Antigen Receptor T-Cell Therapy.

Authors:
Hamzah Abu-Sbeih Tenglong Tang Faisal S Ali Wenyi Luo Sattva S Neelapu Jason R Westin Pablo C Okhuysen Wai Chin Foo Jonathan L Curry David M Richards Phillip S Ge Yinghong Wang

Am J Clin Oncol 2019 Oct;42(10):789-796

Departments of Gastroenterology, Hepatology, and Nutrition.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1097/COC.0000000000000596DOI Listing
October 2019

Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.

Authors:
Paolo Strati Mohamed Amin Amin Ahmed Nathan Fowler Loretta J Nastoupil Felipe Samaniego Luis E Fayad Fredrick B Hagemeister Jorge E Romaguera Alma Rodriguez Michael Wang Jason R Westin Chan Cheah Mansoor Noorani Lei Feng Richard E Davis Sattva S Neelapu

Haematologica 2019 Oct 10. Epub 2019 Oct 10.

The University of Texas MD Anderson Cancer Center

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3324/haematol.2019.230649DOI Listing
October 2019

CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era.

Authors:
Bei Hu Loretta J Nastoupil Sanam Loghavi Jason R Westin Beenu Thakral Luis E Fayad Fredrick Hagemeister Sattva Neelapu Felipe Samaniego Hun J Lee Michael L Wang Michelle Fanale Nathan Fowler Yasuhiro Oki

Leuk Lymphoma 2019 Sep 18:1-9. Epub 2019 Sep 18.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/10428194.2019.1663418DOI Listing
September 2019

Ibrutinib and lenalidomide: when 1+1 = >2.

Authors:
Jason Westin

Blood 2019 Sep;134(13):996-998

MD Anderson Cancer Center.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood.2019002237DOI Listing
September 2019

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma.

Authors:
Neeraj Y Saini Rima M Saliba Gabriela Rondon Farzaneh Maadani Uday Popat Chitra M Hosing Betul Oran Qaiser Bashir Amanda Olson Yago Nieto Amin Alousi Partow Kebriaei Samer Srour Rohtesh Mehta Paolo Anderlini Elizabeth J Shpall Muzaffar H Qazilbash Issa F Khouri Luis Fayad Hun Lee Nathan Fowler Simrit Parmar Jason Westin Fredrick Hagemeister Richard E Champlin Stefan O Ciurea

Biol Blood Marrow Transplant 2019 07 11;25(7):1340-1346. Epub 2019 Feb 11.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.bbmt.2019.02.002DOI Listing
July 2019

Dynamic Risk Profiling Using Serial Tumor Biomarkers for Personalized Outcome Prediction.

Authors:
David M Kurtz Mohammad S Esfahani Florian Scherer Joanne Soo Michael C Jin Chih Long Liu Aaron M Newman Ulrich Dührsen Andreas Hüttmann Olivier Casasnovas Jason R Westin Matthais Ritgen Sebastian Böttcher Anton W Langerak Mark Roschewski Wyndham H Wilson Gianluca Gaidano Davide Rossi Jasmin Bahlo Michael Hallek Robert Tibshirani Maximilian Diehn Ash A Alizadeh

Cell 2019 Jul 4;178(3):699-713.e19. Epub 2019 Jul 4.

Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA; Division of Hematology, Department of Medicine, Stanford University, Stanford, CA, USA; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA, USA; Stanford Cancer Institute, Stanford University, Stanford, CA, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.cell.2019.06.011DOI Listing
July 2019

Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion.

Authors:
Michael R Bishop Richard T Maziarz Edmund K Waller Ulrich Jäger Jason R Westin Joseph P McGuirk Isabelle Fleury Harald Holte Peter Borchmann Christopher Del Corral Ranjan Tiwari Özlem Anak Rakesh Awasthi Lida Pacaud Vadim V Romanov Stephen J Schuster

Blood Adv 2019 Jul;3(14):2230-2236

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/bloodadvances.2019000151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6650727PMC
July 2019

Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.

Authors:
Chelsea C Pinnix Jillian R Gunther Sarah A Milgrom Ruben J Cruz Chamorro L Jeffrey Medeiros Joseph D Khoury Behrang Amini Sattva Neelapu Hun J Lee Jason Westin Nathan Fowler Loretta Nastoupil Bouthaina Dabaja

Int J Radiat Oncol Biol Phys 2019 06 12;104(2):447-455. Epub 2019 Feb 12.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2019.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839887PMC
June 2019

Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.

Authors:
Paolo Strati Seung Tae Lee Purnima Teegavarupu Anusha Karri Saswatha Anireddy Fredrick B Hagemeister Jorge Romaguera Luis E Fayad Maria A Rodriguez Felipe Samaniego Nathan Fowler Jason Westin Michael Wang Hun Ju Lee Chelsea Pinnix Jillian R Gunther Bouthaina Dabaja Lei Feng Richard Eric Davis Sattva S Neelapu

Am J Hematol 2019 06 6;94(6):E150-E153. Epub 2019 Mar 6.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/ajh.25447DOI Listing
June 2019

Lenalidomide plus rituximab (R ) in previously untreated marginal zone lymphoma: subgroup analysis and long-term follow-up of an open-label phase 2 trial.

Authors:
Melody R Becnel Loretta J Nastoupil Felipe Samaniego Richard E Davis M J You Michael Green Fredrick B Hagemeister Michelle A Fanale Luis E Fayad Jason R Westin Michael Wang Yasuhiro Oki Sheryl G Forbes Lei Feng Sattva S Neelapu Nathan H Fowler

Br J Haematol 2019 Jun 28;185(5):874-882. Epub 2019 Mar 28.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.15843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6619290PMC
June 2019

Targetable genetic alterations of () drive immunoglobulin expression in diffuse large B cell lymphoma.

Authors:
Neeraj Jain Keenan Hartert Saber Tadros Warren Fiskus Ondrej Havranek Man Chun John Ma Alyssa Bouska Tayla Heavican Dhiraj Kumar Qing Deng Dalia Moore Christine Pak Chih Long Liu Andrew J Gentles Elena Hartmann Robert Kridel Karin Ekstrom Smedby Gunnar Juliusson Richard Rosenquist Randy D Gascoyne Andreas Rosenwald Filippo Giancotti Sattva S Neelapu Jason Westin Julie M Vose Matthew A Lunning Timothy Greiner Scott Rodig Javeed Iqbal Ash A Alizadeh R Eric Davis Kapil Bhalla Michael R Green

Sci Transl Med 2019 Jun;11(497)

Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1126/scitranslmed.aav5599DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724184PMC
June 2019

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

Authors:
Dai Chihara Yasuhiro Oki Michelle A Fanale Jason R Westin Loretta J Nastoupil Sattva Neelapu Luis Fayad Nathan H Fowler Chan Yoon Cheah

Ann Hematol 2019 May 8;98(5):1169-1176. Epub 2019 Jan 8.

Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, WA, Australia.

View Article

Download full-text PDF

 Source
http://link.springer.com/10.1007/s00277-018-3571-7
Publisher Site
http://dx.doi.org/10.1007/s00277-018-3571-7DOI Listing
May 2019

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Authors:
Chelsea C Pinnix Bouthaina S Dabaja Sarah A Milgrom Grace L Smith Zeinab Abou Yehia Loretta Nastoupil Jorge Romaguera Francesco Turturro Nathan Fowler Luis Fayad Jason Westin Sattva Neelapu Michelle A Fanale Maria A Rodriguez Frederick Hagemeister Hun Ju Lee Yasuhiro Oki Michael Wang Felipe Samaniego Linda Chi Bita Esmaeli

Head Neck 2019 May 19;41(5):1546. Epub 2019 Mar 19.

Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/hed.25738DOI Listing
May 2019

Favorable outcomes with de-escalated radiation therapy for limited-stage nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:
Chelsea C Pinnix Sarah A Milgrom Chan Yoon Cheah Jillian R Gunther Ethan B Ludmir Christine F Wogan Loretta J Nastoupil Sattva S Neelapu Jason Westin Hun J Lee Swaminathan P Iyer Raphael E Steiner Luis E Fayad Nathan H Fowler Michael L Wang Felipe Samaniego Maria A Rodriguez Amy E Rich L Jeffrey Medeiros Bouthaina S Dabaja

Blood Adv 2019 05;3(9):1356-1367

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/bloodadvances.2018029140DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517662PMC
May 2019

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma.

Authors:
Grzegorz S Nowakowski Tatyana Feldman Lisa M Rimsza Jason R Westin Thomas E Witzig Pier Luigi Zinzani

Blood Cancer J 2019 05 16;9(6):48. Epub 2019 May 16.

Institute of Hematology, University of Bologna, Bologna, Italy.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/s41408-019-0208-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522601PMC
May 2019

Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.

Authors:
Dai Chihara Yasuhiro Oki Michelle A Fanale Jason R Westin Loretta J Nastoupil Sattva Neelapu Luis Fayad Nathan H Fowler Chan Y Cheah

Br J Haematol 2019 Apr 5;185(2):334-338. Epub 2018 Jul 5.

Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.15444DOI Listing
April 2019

Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue.

Authors:
Ethan B Ludmir Sarah A Milgrom Chelsea C Pinnix Jillian R Gunther Jason Westin Luis E Fayad Joseph D Khoury L Jeffrey Medeiros Bouthaina S Dabaja Loretta J Nastoupil

Clin Lymphoma Myeloma Leuk 2019 04 3;19(4):244-250. Epub 2019 Jan 3.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2018.12.016DOI Listing
April 2019

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.

Authors:
Ziju Y Xu-Monette Min Xiao Qingyan Au Raghav Padmanabhan Bing Xu Nicholas Hoe Sandra Rodríguez-Perales Raul Torres-Ruiz Ganiraju C Manyam Carlo Visco Yi Miao Xiaohong Tan Hongwei Zhang Alexandar Tzankov Jing Wang Karen Dybkær Wayne Tam Hua You Govind Bhagat Eric D Hsi Maurilio Ponzoni Andrés J M Ferreri Michael B Møller Miguel A Piris J Han van Krieken Jane N Winter Jason R Westin Lan V Pham L Jeffrey Medeiros George Z Rassidakis Yong Li Gordon J Freeman Ken H Young

Cancer Immunol Res 2019 Apr 11;7(4):644-657. Epub 2019 Feb 11.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-18-0439DOI Listing
April 2019

Reply to J. Wang et al.

Authors:
David M Kurtz Florian Scherer Michael C Jin Joanne Soo Alexander F M Craig Mohammad S Esfahani Jacob J Chabon Henning Stehr Chih Long Liu Robert Tibshirani Lauren S Maeda Neel K Gupta Michael S Khodadoust Ranjana H Advani Aaron M Newman Ulrich Dührsen Andreas Hüttmann Michel Meignan Olivier Casasnovas Jason R Westin Mark Roschewski Wyndham H Wilson Gianluca Gaidano Davide Rossi Maximilian Diehn Ash A Alizadeh

J Clin Oncol 2019 Mar 12;37(9):755-757. Epub 2019 Feb 12.

David M. Kurtz, MD, PhD; Florian Scherer, MD; Michael C. Jin; Joanne Soo; Alexander F.M. Craig, MPhil; Mohammad S. Esfahani, PhD; Jacob J. Chabon, PhD; Henning Stehr, PhD; Chih Long Liu, PhD; Robert Tibshirani, PhD; Lauren S. Maeda, MD; Neel K. Gupta, MD; Michael S. Khodadoust, MD, PhD; Ranjana H. Advani, MD; and Aaron M. Newman, PhD, Stanford University, Stanford, CA; Ulrich Dührsen, MD; and Andreas Hüttmann, MD, University Hospital Essen, Essen, Germany; Michel Meignan, MD, PhD, Hôpitaux Universitaires Henri Mondor, Creteil, France; Olivier Casasnovas, MD, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, MD, The University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski, MD; and Wyndham H. Wilson, MD, PhD, National Institutes of Health, Bethesda, MD; Gianluca Gaidano, MD, PhD; and Davide Rossi, MD, PhD, University of Eastern Piedmont, Novara, Italy, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland; and Maximilian Diehn, MD, PhD; and Ash A. Alizadeh, MD, PhD, Stanford University, Stanford, CA.

View Article

Download full-text PDF

 Source
http://ascopubs.org/doi/10.1200/JCO.18.01907
Publisher Site
http://dx.doi.org/10.1200/JCO.18.01907DOI Listing
March 2019

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.

Authors:
Winnie S Liang Jo-Anne Vergilio Bodour Salhia Helen J Huang Yasuhiro Oki Ignacio Garrido-Laguna Haeseong Park Jason R Westin Funda Meric-Bernstam David Fabrizio Vincent A Miller Philip J Stephens Michelle A Fanale Jeffrey S Ross Filip Janku

Oncologist 2019 02 14;24(2):219-228. Epub 2018 Aug 14.

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1634/theoncologist.2018-0058DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369943PMC
February 2019

Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy.

Authors:
Alison K Yoder Jillian R Gunther Sarah A Milgrom Dragan Mirkovic Loretta Nastoupil Sattva Neelapu Michelle Fanale Nathan Fowler Jason Westin Hun Ju Lee M Alma Rodriguez Swaminathan P Iyer Luis Fayad Yago L Nieto Chitra Hosing Sairah Ahmed L Jeffrey Medeiros Joseph D Khoury Naveen Garg Behrang Amini Bouthaina S Dabaja Chelsea C Pinnix

Clin Lymphoma Myeloma Leuk 2019 01 10;19(1):e51-e61. Epub 2018 Sep 10.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S21522650183068
Publisher Site
http://dx.doi.org/10.1016/j.clml.2018.09.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371800PMC
January 2019

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Authors:
Stephen J Schuster Michael R Bishop Constantine S Tam Edmund K Waller Peter Borchmann Joseph P McGuirk Ulrich Jäger Samantha Jaglowski Charalambos Andreadis Jason R Westin Isabelle Fleury Veronika Bachanova S Ronan Foley P Joy Ho Stephan Mielke John M Magenau Harald Holte Serafino Pantano Lida B Pacaud Rakesh Awasthi Jufen Chu Özlem Anak Gilles Salles Richard T Maziarz

N Engl J Med 2019 01 1;380(1):45-56. Epub 2018 Dec 1.

From the Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia (S.J.S.); the Hematopoietic Cellular Therapy Program, University of Chicago Medicine, Chicago (M.R.B.); Peter MacCallum Cancer Centre, St. Vincent's Hospital and University of Melbourne, Melbourne, VIC (C.S.T.), and the Royal Prince Alfred Hospital and Department of Medicine, University of Sydney, Sydney (P.J.H.) - both in Australia; Winship Cancer Institute of Emory University, Bone Marrow and Stem Cell Transplant Center, Atlanta (E.K.W.); the Department of Hematology and Oncology, University Hospital of Cologne, Cologne (P.B.), and the Würzburg University Medical Center, Center for Allogeneic Stem Cell Transplantation, Würzburg (S.M.) - both in Germany; the Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City (J.P.M.); the Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna (U.J.); James Cancer Hospital and Solove Research Institute, Ohio State University Comprehensive Cancer Center, Columbus (S.J.); the Department of Hematology and Blood and Marrow Transplant, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco (C.A.); the Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston (J.R.W.); Maisonneuve-Rosemont Hospital, University of Montreal, Montreal (I.F.), and the Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON (S.R.F.) - both in Canada; the Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis (V.B.); Karolinska Institutet and University Hospital, Department of Laboratory Medicine/Department of Cell Therapy and Allogeneic Stem Cell Transplantation, Stockholm (S.M.); University of Michigan Comprehensive Cancer Center, Ann Arbor (J.M.M.); the Department of Oncology, Oslo University Hospital, Oslo (H.H.); Novartis Pharma, Basel, Switzerland (S.P., O.A.); Novartis Pharmaceuticals (L.B.P., J.C.) and Novartis Institutes for BioMedical Research (R.A.), East Hanover, NJ; the Department of Hematology, Hospices Civils de Lyon, Université de Lyon, Lyon, France (G.S.); and the Center for Hematologic Malignancies, Oregon Health and Science University Knight Cancer Institute, Portland (R.T.M.).

View Article

Download full-text PDF

 Source
http://www.nejm.org/doi/10.1056/NEJMoa1804980
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804980DOI Listing
January 2019

The Other Side of CAR T-Cell Therapy: Cytokine Release Syndrome, Neurologic Toxicity, and Financial Burden.

Authors:
Bianca Santomasso Carlos Bachier Jason Westin Katayoun Rezvani Elizabeth J Shpall

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:433-444. Epub 2019 May 17.

3 The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/EDBK_238691DOI Listing
January 2019

Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure.

Authors:
Ethan B Ludmir Sarah A Milgrom Chelsea C Pinnix Jillian R Gunther Jason Westin Yasuhiro Oki Luis E Fayad L Jeffrey Medeiros Bouthaina S Dabaja Loretta J Nastoupil

Leuk Lymphoma 2018 12 26;59(12):2896-2903. Epub 2018 Apr 26.

b Department of Lymphoma/Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

 Source
https://www.tandfonline.com/doi/full/10.1080/10428194.2018.1
Publisher Site
http://dx.doi.org/10.1080/10428194.2018.1460825DOI Listing
December 2018

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

Authors:
David M Kurtz Florian Scherer Michael C Jin Joanne Soo Alexander F M Craig Mohammad Shahrokh Esfahani Jacob J Chabon Henning Stehr Chih Long Liu Robert Tibshirani Lauren S Maeda Neel K Gupta Michael S Khodadoust Ranjana H Advani Ronald Levy Aaron M Newman Ulrich Dührsen Andreas Hüttmann Michel Meignan René-Olivier Casasnovas Jason R Westin Mark Roschewski Wyndham H Wilson Gianluca Gaidano Davide Rossi Maximilian Diehn Ash A Alizadeh

J Clin Oncol 2018 10 20;36(28):2845-2853. Epub 2018 Aug 20.

David M. Kurtz, Florian Scherer, Michael C. Jin, Joanne Soo, Alexander F.M. Craig, Mohammad Shahrokh Esfahani, Jacob J. Chabon, Henning Stehr, Chih Long Liu, Robert Tibshirani, Lauren S. Maeda, Neel K. Gupta, Michael S. Khodadoust, Ranjana H. Advani, Ronald Levy, Aaron M. Newman, Maximilian Diehn, and Ash A. Alizadeh, Stanford University, Stanford, CA; Florian Scherer, University Medical Center Freiburg, Freiburg; Ulrich Dührsen and Andreas Hüttmann, University Hospital Essen, Essen, Germany; Michel Meignan, Hôpitaux Universitaires Henri Mondor, Creteil; René-Olivier Casasnovas, Hôpital Le Bocage, Centre Hospitalier Universitaire, Dijon, France; Jason R. Westin, University of Texas MD Anderson Cancer Center, Houston, TX; Mark Roschewski and Wyndham H. Wilson, National Cancer Institute, National Institutes of Health, Bethesda, MD; Gianluca Gaidano and Davide Rossi, University of Eastern Piedmont, Novara, Italy; and Davide Rossi, Oncology Institute of Southern Switzerland and Institute of Oncology Research, Bellinzona, Switzerland.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1200/JCO.2018.78.5246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161832PMC
October 2018

Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors.

Authors:
Preetesh Jain Rashmi Kanagal-Shamanna F Anthony San Lucas Loretta Nastoupil Jorge Romaguera Luis Fayad Yasuhiro Oki Jason R Westin Leonard Jeffrey Medeiros Michael Wang Nathan Fowler

Br J Haematol 2018 09 2;182(5):718-723. Epub 2017 Aug 2.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5904008PMC
September 2018

Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas.

Authors:
Lan V Pham Shengjian Huang Hui Zhang Jun Zhang Taylor Bell Shouhao Zhou Elizabeth Pogue Zhiyong Ding Laura Lam Jason Westin R Eric Davis Ken H Young L Jeffrey Medeiros Richard J Ford Krystle Nomie Leo Zhang Michael Wang

Clin Cancer Res 2018 08 17;24(16):3967-3980. Epub 2018 Apr 17.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-3004DOI Listing
August 2018

Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).

Authors:
Preetesh Jain Jorge Romaguera Samer A Srour Hun J Lee Frederick Hagemeister Jason Westin Luis Fayad Felipe Samaniego Maria Badillo Liang Zhang Lorreta Nastoupil Rashmi Kanagal-Shamanna Nathan Fowler Michael L Wang

Br J Haematol 2018 08 22;182(3):404-411. Epub 2018 May 22.

Department of Lymphoma and myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.15411DOI Listing
August 2018

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.

Authors:
Dai Chihara Michelle A Fanale Roberto N Miranda Mansoor Noorani Jason R Westin Loretta J Nastoupil Fredrick B Hagemeister Luis E Fayad Jorge E Romaguera Felipe Samaniego Francesco Turturro Hun J Lee Sattva S Neelapu M Alma Rodriguez Michael Wang Nathan H Fowler Richard E Davis L Jeffrey Medeiros Yasuhiro Oki

PLoS One 2018 14;13(3):e0191461. Epub 2018 Mar 14.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.

View Article

Download full-text PDF

 Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0191461PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851529PMC
June 2018

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Authors:
Chelsea C Pinnix Bouthaina S Dabaja Sarah A Milgrom Grace L Smith Zeinab Abou Loretta Nastoupil Jorge Romaguera Francesco Turturro Nathan Fowler Luis Fayad Jason Westin Sattva Neelapu Michelle A Fanale Maria A Rodriguez Frederick Hagemeister Hun Ju Lee Yasuhiro Oki Michael Wang Felipe Samaniego Linda Chi Bita Esmaeli

Head Neck 2018 06 21;40(6):1335. Epub 2018 Feb 21.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1002/hed.25149
Publisher Site
http://dx.doi.org/10.1002/hed.25149DOI Listing
June 2018

Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.

Authors:
Chelsea C Pinnix Andrea K Ng Bouthaina S Dabaja Sarah A Milgrom Jillian R Gunther C David Fuller Grace L Smith Zeinab Abou Yehia Wei Qiao Christine F Wogan Mani Akhtari Osama Mawlawi L Jeffrey Medeiros Hubert H Chuang William Martin-Doyle Philippe Armand Ann S LaCasce Yasuhiro Oki Michelle Fanale Jason Westin Sattva Neelapu Loretta Nastoupil

Blood Adv 2018 06;2(11):1334-1343

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/bloodadvances.2018017681DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5998935PMC
June 2018

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.

Authors:
Dai Chihara Nathan H Fowler Yasuhiro Oki Michelle A Fanale Loretta J Nastoupil Jason R Westin Luis E Fayad Sattva S Neelapu Chan Yoon Cheah

Oncotarget 2018 Jun 22;9(48):28897-28902. Epub 2018 Jun 22.

Department of Haematology, Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.18632/oncotarget.25622DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034756PMC
June 2018

University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL.

Authors:
Natalie Galanina Sonali M Smith Chuanhong Liao Adam Petrich Bernadette Libao Ronald Gartenhaus Jason R Westin Kenneth S Cohen James A Knost Walter M Stadler Austin Doyle Theodore Karrison Leo I Gordon Andrew M Evens

Br J Haematol 2018 04 17;181(2):264-267. Epub 2017 Apr 17.

Division of Hematology/OncologyTufts University School of Medicine, Boston, MA, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785463PMC
April 2018

Phase-I and randomized phase-II trial of panobinostat in combination with ICE (ifosfamide, carboplatin, etoposide) in relapsed or refractory classical Hodgkin lymphoma.

Authors:
Bei Hu Anas Younes Jason R Westin Francesco Turturro Linda Claret Lei Feng Nathan Fowler Sattva Neelapu Jorge Romaguera Fredrick B Hagemeister Maria Alma Rodriguez Felipe Samaniego Luis E Fayad Amanda R Copeland Loretta J Nastoupil Yago Nieto Michelle A Fanale Yasuhiro Oki

Leuk Lymphoma 2018 04 9;59(4):863-870. Epub 2017 Aug 9.

a Department of Lymphoma and Myeloma , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/10428194.2017.1359741DOI Listing
April 2018

Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.

Authors:
Sarah A Milgrom Chelsea C Pinnix T Linda Chi Thinh H Vu Jillian R Gunther Tommy Sheu Nathan Fowler Jason R Westin Loretta J Nastoupil Yasuhiro Oki Luis E Fayad Sattva Neelapu Maria Alma Rodriguez Frederick B Hagemeister Michelle A Fanale Hun J Lee Chitra Hosing Sairah Ahmed Yago Nieto Elizabeth J Shpall Bouthaina S Dabaja

Int J Radiat Oncol Biol Phys 2018 04 6;100(5):1146-1154. Epub 2018 Jan 6.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2018.01.003DOI Listing
April 2018

Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.

Authors:
Sattva S Neelapu Sudhakar Tummala Partow Kebriaei William Wierda Cristina Gutierrez Frederick L Locke Krishna V Komanduri Yi Lin Nitin Jain Naval Daver Jason Westin Alison M Gulbis Monica E Loghin John F de Groot Sherry Adkins Suzanne E Davis Katayoun Rezvani Patrick Hwu Elizabeth J Shpall

Nat Rev Clin Oncol 2018 Jan 19;15(1):47-62. Epub 2017 Sep 19.

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/nrclinonc.2017.148DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733403PMC
January 2018

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

Authors:
Paolo Strati Nathan Fowler Sergio Pina-Oviedo L Jeffrey Medeiros Michael J Overman Jorge E Romaguera Loretta Nastoupil Michael Wang Fredrick B Hagemeister Alma Rodriguez Yasuhiro Oki Jason Westin Francesco Turturro Sattva S Neelapu Luis Fayad

Clin Lymphoma Myeloma Leuk 2018 01 14;18(1):e103-e108. Epub 2017 Nov 14.

Department of Lymphoma and Myeloma, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2017.11.001DOI Listing
January 2018

Preclinical efficacy and biological effects of the oral proteasome inhibitor ixazomib in diffuse large B-cell lymphoma.

Authors:
Wei Liu Juan Chen Archito T Tamayo Changgeng Ruan Li Li Shouhao Zhou Chan Shen Ken H Young Jason Westin Richard E Davis Shimin Hu Leonard J Medeiros Richard J Ford Lan V Pham

Oncotarget 2018 Jan 21;9(1):346-360. Epub 2017 Aug 21.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.18632/oncotarget.20378DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787470PMC
January 2018

Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement.

Authors:
Dai Chihara Nathan H Fowler Yasuhiro Oki Michelle A Fanale Luis E Fayad Jason R Westin Fredrick B Hagemeister

Br J Haematol 2017 12 9;179(5):851-854. Epub 2016 Aug 9.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14267DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6063086PMC
December 2017

Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma.

Authors:
Jennifer C Ho Bouthaina S Dabaja Sarah A Milgrom Grace L Smith Jay P Reddy Ali Mazloom Ken H Young Lijuan Deng L Jeffrey Medeiros Wenli Dong Pamela K Allen Therese Y Andraos Nathan H Fowler Loretta J Nastoupil Yasuhiro Oki Luis E Fayad Francesco Turturro Sattva S Neelapu Jason Westin Fredrick B Hagemeister Maria Alma Rodriguez Chelsea C Pinnix

Leuk Lymphoma 2017 12 9;58(12):2833-2844. Epub 2017 May 9.

a Department of Radiation Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1080/10428194.2017.1312381DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042648PMC
December 2017

Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma.

Authors:
Andrés E Quesada L Jeffrey Medeiros Parth A Desai Pei Lin Jason R Westin Huda M Hawsawi Peng Wei Guilin Tang Adam C Seegmiller Nishitha M Reddy C Cameron Yin Wei Wang Jie Xu Roberto N Miranda Zhuang Zuo Shaoying Li

Mod Pathol 2017 12 4;30(12):1688-1697. Epub 2017 Aug 4.

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1038/modpathol.2017.93DOI Listing
December 2017

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:
Sattva S Neelapu Frederick L Locke Nancy L Bartlett Lazaros J Lekakis David B Miklos Caron A Jacobson Ira Braunschweig Olalekan O Oluwole Tanya Siddiqi Yi Lin John M Timmerman Patrick J Stiff Jonathan W Friedberg Ian W Flinn Andre Goy Brian T Hill Mitchell R Smith Abhinav Deol Umar Farooq Peter McSweeney Javier Munoz Irit Avivi Januario E Castro Jason R Westin Julio C Chavez Armin Ghobadi Krishna V Komanduri Ronald Levy Eric D Jacobsen Thomas E Witzig Patrick Reagan Adrian Bot John Rossi Lynn Navale Yizhou Jiang Jeff Aycock Meg Elias David Chang Jeff Wiezorek William Y Go

N Engl J Med 2017 12 10;377(26):2531-2544. Epub 2017 Dec 10.

From the University of Texas M.D. Anderson Cancer Center, Houston (S.S.N., J.R.W.); H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (F.L.L., J.C.C.); Washington University and Siteman Cancer Center, St. Louis (N.L.B., A. Ghobadi); University of Miami, Miami (L.J.L., K.V.K.); Stanford University, Stanford (D.B.M., R.L.), City of Hope National Medical Center, Duarte (T.S.), University of California at Los Angeles, Los Angeles (J.M.T.), University of California at San Diego, San Diego (J.E.C.), and Kite Pharma, Santa Monica (A.B., J.R., L.N., Y.J., J.A., M.E., D.C., J.W., W.Y.G.) - all in California; Dana-Farber Cancer Institute, Boston (C.A.J., E.D.J.); Montefiore Medical Center, Bronx (I.B.), and the University of Rochester School of Medicine, Rochester (J.W.F., P.R.) - both in New York; Vanderbilt University Medical Center (O.O.O.) and the Sarah Cannon Research Institute and Tennessee Oncology (I.W.F.), Nashville; Mayo Clinic, Rochester, MN (Y.L., T.E.W.); Loyola University Medical Center, Maywood, IL (P.J.S.); John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ (A. Goy); Cleveland Clinic, Cleveland (B.T.H., M.R.S.); Karmanos Cancer Center, Wayne State University, Detroit (A.D.); University of Iowa Carver College of Medicine, Iowa City (U.F.); Colorado Blood Cancer Institute, Denver (P.M.S.); Banner M.D. Anderson Cancer Center, Gilbert, AZ (J.M.); and Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (I.A.).

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1056/NEJMoa1707447DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882485PMC
December 2017

Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma.

Authors:
Dai Chihara Jason R Westin Roberto N Miranda Chan Y Cheah Yasuhiro Oki Francesco Turturro Jorge E Romaguera Sattva S Neelapu Lorreta J Nastoupil Luis E Fayad M Alma Rodriguez Nathan H Fowler Robert Z Orlowski Michael Wang Fredrick B Hagemeister L Jeffrey Medeiros Michelle A Fanale

Br J Haematol 2017 11 5;179(3):503-506. Epub 2016 Jul 5.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14226DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920532PMC
November 2017

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.

Authors:
Michael Crump Sattva S Neelapu Umar Farooq Eric Van Den Neste John Kuruvilla Jason Westin Brian K Link Annette Hay James R Cerhan Liting Zhu Sami Boussetta Lei Feng Matthew J Maurer Lynn Navale Jeff Wiezorek William Y Go Christian Gisselbrecht

Blood 2017 10 3;130(16):1800-1808. Epub 2017 Aug 3.

Lymphoma Academic Research Organization, Pierre-Bénite, France.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2017-03-769620DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649550PMC
October 2017

Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center.

Authors:
Xin Li Zijun Y Xu-Monette Shuhua Yi Bouthaina S Dabaja Ganiraju C Manyam Jason Westin Nathan Fowler Roberto N Miranda Mingzhi Zhang Judith A Ferry L Jeffrey Medeiros Nancy L Harris Ken H Young

Am J Surg Pathol 2017 Oct;41(10):1309-1321

*Department of Oncology, The First Affiliated Hospital Zhengzhou University, Zhengzhou, China Departments of †Hematopathology ‡Radiation Oncology §Bioinformatics and Computational Biology ∥Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center #Graduate School of Biomedical Sciences, The University of Texas Health Science Center, Houston, TX ¶Department of Pathology, Harvard University Medical School, Boston, MA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1097/PAS.0000000000000923DOI Listing
October 2017

Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.

Authors:
Ondrej Havranek Jingda Xu Stefan Köhrer Zhiqiang Wang Lisa Becker Justin M Comer Jared Henderson Wencai Ma John Man Chun Ma Jason R Westin Dipanjan Ghosh Nicholas Shinners Luhong Sun Allen F Yi Anusha R Karri Jan A Burger Tomasz Zal R Eric Davis

Blood 2017 08 23;130(8):995-1006. Epub 2017 Jun 23.

Department of Lymphoma and Myeloma.

View Article

Download full-text PDF

 Source
http://www.bloodjournal.org/lookup/doi/10.1182/blood-2016-10
Publisher Site
http://dx.doi.org/10.1182/blood-2016-10-747303DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813722PMC
August 2017

Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma.

Authors:
Michelle A Fanale Chan Yoon Cheah Amy Rich L Jeffrey Medeiros Chao-Ming Lai Yasuhiro Oki Jorge E Romaguera Luis E Fayad F B Hagemeister Felipe Samaniego Maria A Rodriguez Sattva S Neelapu Hun J Lee Loretta Nastoupil Nathan H Fowler Francesco Turturro Jason R Westin Michael L Wang Peter McLaughlin Chelsea C Pinnix Sarah A Milgrom Bouthaina Dabaja Sandra B Horowitz Anas Younes

Blood 2017 07 18;130(4):472-477. Epub 2017 May 18.

Lymphoma Department, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1182/blood-2017-02-766121DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5578726PMC
July 2017

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Authors:
Chelsea C Pinnix Bouthaina S Dabaja Sarah A Milgrom Grace L Smith Zeinab Abou Loretta Nastoupil Jorge Romaguera Francesco Turturro Nathan Fowler Luis Fayad Jason Westin Sattva Neelapu Michelle A Fanale Maria A Rodriguez Frederick Hagemeister Hun Ju Lee Yasuhiro Oki Michael Wang Felipe Samaniego Linda Chi Bita Esmaeli

Head Neck 2017 06 3;39(6):1095-1100. Epub 2017 Apr 3.

Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1002/hed.24717DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044206PMC
June 2017

Hematology oncology practice in the Asia-Pacific APHCON survey results from the 6th international hematologic malignancies conference: bridging the gap 2015, Beijing, China.

Authors:
Xiao Jun Huang Kaiyan Liu David Ritchie Borje Andersson Jin Lu Jian Hou Adolfo de la Fuente Burguera JianXiang Wang Allen Yeoh Chenhua Yan Daobin Zhou Daryl Tan Dong Wook Kim Depei Wu Elizabeth Shpall Stephen Kornblau Sattava Neelapu Suradej Hongeng Jianyong Li Jiong Hu Lian Sheng Zhang Michael Wang Pankaj Malhotra Qian Jiang Yazhen Qin Raymond Wong Richard Champlin Frederick Hagemeister Jason Westin Swaminathan Iyer Vikram Mathews Yu Wang Yu Hu Zhijian Xiao Zonghong Shao Robert Z Orlowski Chor Sang Chim Stephen Mulligan Miguel Sanz Keiya Ozawa Simrit Parmar Surapol Issaragrisil

Oncotarget 2017 Jun;8(25):41620-41630

Faculty of Medicine Siriraj Hospital, Bangkok, Thailand.

View Article

Download full-text PDF

 Source
http://www.oncotarget.com/fulltext/15655
Publisher Site
http://dx.doi.org/10.18632/oncotarget.15655DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522281PMC
June 2017

Phase II Study of Bortezomib in Combination with Cyclophosphamide and Rituximab for Relapsed or Refractory Mantle Cell Lymphoma.

Authors:
Hun Ju Lee Jorge E Romaguera Lei Feng Aakash P Desai Liang Zhang Michelle Fanale Felipe Samaniego Fredrick B Hagemeister Luis E Fayad Maria A Rodriguez Jeffrey L Medeiros Kimberly Hartig Krystle Nomie Makhdum Ahmed Maria Badillo Haige Ye Yasuhiro Oki Pei Lin Loretta Nastoupil Jason Westin Michael Wang

Oncologist 2017 05 13;22(5):549-553. Epub 2017 Apr 13.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1634/theoncologist.2016-0328DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423503PMC
May 2017

High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study.

Authors:
Loretta J Nastoupil Peter McLaughlin Lei Feng Sattva S Neelapu Felipe Samaniego Fredrick B Hagemeister Ana Ayala Jorge E Romaguera Andre H Goy Eleanor Neal Michael Wang Luis Fayad Michelle A Fanale Yasuhiro Oki Jason R Westin Maria A Rodriguez Fernando Cabanillas Nathan H Fowler

Br J Haematol 2017 04 24;177(2):263-270. Epub 2017 Mar 24.

Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14541DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901692PMC
April 2017

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.

Authors:
Chelsea C Pinnix Therese Y Andraos Bouthaina Dabaja Sarah Milgrom Grace Smith Dai Chihara Andrea Ng Luis E Fayad Yasuhiro Oki Sattva Neelapu Jason Westin M Alma Rodriguez Loretta J Nastoupil

Adv Radiat Oncol 2017 Jul-Sep;2(3):370-380. Epub 2017 Apr 22.

Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
https://linkinghub.elsevier.com/retrieve/pii/S24521094173006
Publisher Site
http://dx.doi.org/10.1016/j.adro.2017.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5605286PMC
April 2017

The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.

Authors:
Dai Chihara Michelle A Fanale Roberto N Miranda Mansoor Noorani Jason R Westin Loretta J Nastoupil Fredrick B Hagemeister Luis E Fayad Jorge E Romaguera Felipe Samaniego Francesco Turturro Hun J Lee Sattva S Neelapu M Alma Rodriguez Michael Wang Nathan H Fowler Richard E Davis L Jeffrey Medeiros Chitra Hosing Yago L Nieto Yasuhiro Oki

Br J Haematol 2017 03 16;176(5):750-758. Epub 2016 Dec 16.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14477DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836501PMC
March 2017

Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma.

Authors:
Dai Chihara Jason R Westin Yasuhiro Oki Mohamed A Ahmed Bryan Do Luis E Fayad Fredrick B Hagemeister Jorge E Romaguera Michelle A Fanale Hun J Lee Francesco Turturro Felipe Samaniego Sattva S Neelapu M Alma Rodriguez Nathan H Fowler Michael Wang Richard E Davis Loretta J Nastoupil

Cancer 2016 Oct 28;122(20):3145-3151. Epub 2016 Jun 28.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://doi.wiley.com/10.1002/cncr.30173
Publisher Site
http://dx.doi.org/10.1002/cncr.30173DOI Listing
October 2016

Prognostic significance of baseline peripheral absolute neutrophil, monocyte and serum β2-microglobulin level in patients with diffuse large b-cell lymphoma: a new prognostic model.

Authors:
Yiming Chen Sattva Neelapu Lei Feng Weiqi Bi Tian-Hui Yang Michael Wang Michelle A Fanale Jason R Westin Fredrick B Hagemeister Luis E Fayad Jorge E Romaguera Felipe Samaniego Francesco Turturro Nathan H Fowler Peter McLaughlin Fernando Cabanillas Yasuhiro Oki Loretta J Nastoupil Alma Rodriguez

Br J Haematol 2016 Oct 22;175(2):290-299. Epub 2016 Jul 22.

Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.14237DOI Listing
October 2016

What to Do With Success? The Optimist's Creed in Relapsed Hodgkin Lymphoma.

Authors:
Amir K Issa Jason R Westin

Clin Lymphoma Myeloma Leuk 2016 09 8;16(9):483-487. Epub 2016 Jun 8.

Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2016.06.011DOI Listing
September 2016

Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.

Authors:
Chelsea C Pinnix Eleanor M Osborne Dai Chihara Peter Lai Shouhao Zhou Mildred M Ramirez Yasuhiro Oki Frederick B Hagemeister Alma M Rodriguez Felipe Samaniego Nathan Fowler Jorge E Romaguera Francesco Turturro Luis Fayad Jason R Westin Loretta Nastoupil Sattva S Neelapu Chan Y Cheah Bouthaina S Dabaja Sarah A Milgrom Grace L Smith Patricia Horace Andrea Milbourne Christine F Wogan Leslie Ballas Michelle A Fanale

JAMA Oncol 2016 Aug;2(8):1065-9

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1001/jamaoncol.2016.1396DOI Listing
August 2016

Deeper Insights Into Vanishing Bile Duct Syndrome in Lymphoma: A Perplexing Entity.

Authors:
Vishwanath Sathyanarayanan Wai Chin Foo Michelle Fanale Jason Westin

Clin Lymphoma Myeloma Leuk 2016 05 27;16(5):e65-70. Epub 2016 Feb 27.

Division of Cancer Medicine, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2016.02.035DOI Listing
May 2016

Treatment of chronic myelogenous leukemia as a paradigm for solid tumors: how targeted agents in newly diagnosed disease transformed outcomes.

Authors:
Jason R Westin Hagop Kantarjian Razelle Kurzrock

Am Soc Clin Oncol Educ Book 2012 :179-85

From the Department of Leukemia; Department of Lymphoma and Myeloma; Department of Investigational Cancer Therapeutics, University of Texas M. D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.14694/EdBook_AM.2012.32.179DOI Listing
April 2016

Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.

Authors:
Chelsea C Pinnix Jatin J Shah Hubert Chuang Colleen M Costelloe L Jeffrey Medeiros Christine F Wogan Valerie Reed Grace L Smith Sarah Milgrom Krina Patel Jinhai Huo Francesco Turturro Jorge Romaguera Luis Fayad Yasuhiro Oki Michelle A Fanale Jason Westin Loretta Nastoupil Fredrick B Hagemeister Alma Rodriguez Muzaffar Qazilbash Nina Shah Qaiser Bashir Sairah Ahmed Yago Nieto Chitra Hosing Eric Rohren Bouthaina Dabaja

Clin Lymphoma Myeloma Leuk 2016 Mar 22;16(3):122-8. Epub 2015 Dec 22.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2015.12.008DOI Listing
March 2016

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial.

Authors:
Michael L Wang Hun Lee Hubert Chuang Nicolaus Wagner-Bartak Frederick Hagemeister Jason Westin Luis Fayad Felipe Samaniego Francesco Turturro Yasuhiro Oki Wendy Chen Maria Badillo Krystle Nomie Maria DeLa Rosa Donglu Zhao Laura Lam Alicia Addison Hui Zhang Ken H Young Shaoying Li David Santos L Jeffrey Medeiros Richard Champlin Jorge Romaguera Leo Zhang

Lancet Oncol 2016 Jan 28;17(1):48-56. Epub 2015 Nov 28.

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://www.thelancet.com/pdfs/journals/lanonc/PIIS1470-2045(
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S147020451500438
Publisher Site
http://dx.doi.org/10.1016/S1470-2045(15)00438-6DOI Listing
January 2016

Rituximab plus hyper-CVAD alternating with MTX/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center.

Authors:
Dai Chihara Chan Y Cheah Jason R Westin Luis E Fayad Maria A Rodriguez Fredrick B Hagemeister Barbara Pro Peter McLaughlin Anas Younes Felipe Samaniego Andre Goy Fernando Cabanillas Hagop Kantarjian Larry W Kwak Michael L Wang Jorge E Romaguera

Br J Haematol 2016 Jan 9;172(1):80-8. Epub 2015 Dec 9.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.13796DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471614PMC
January 2016

Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic cell tumor of the spleen: case report and literature review.

Authors:
Pauline L Bui Rafael A Vicens Jason R Westin Corey T Jensen

Clin Imaging 2015 May-Jun;39(3):525-8. Epub 2015 Jan 7.

Department of Diagnostic Radiology, Unit 1473, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4009. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clinimag.2014.12.021DOI Listing
November 2015

Busting robustness: using cancer's greatest strength to our advantage.

Authors:
Jason R Westin

Future Oncol 2015 ;11(1):73-7

1400 Holcombe Blvd, Unit 0429, Houston, TX 77030, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2217/fon.14.49DOI Listing
September 2015

Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin lymphoma.

Authors:
Yasuhiro Oki Anas Younes Javier Knickerbocker Felipe Samaniego Loretta Nastoupil Fredrick Hagemeister Jorge Romaguera Nathan Fowler Larry Kwak Jason Westin

Haematologica 2015 Jul 27;100(7):e272-4. Epub 2015 Mar 27.

Department of Lymphoma and Myeloma, University of Texas, MD Anderson Cancer Center, Houston, TX 77030 USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3324/haematol.2015.126557DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486240PMC
July 2015

Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.

Authors:
Randa Tao Pamela K Allen Alma Rodriguez Ferial Shihadeh Chelsea C Pinnix Isadora Arzu Valerie K Reed Yasuhiro Oki Jason R Westin Luis E Fayad L Jeffrey Medeiros Bouthaina Dabaja

Int J Radiat Oncol Biol Phys 2015 May 5;92(1):122-9. Epub 2015 Mar 5.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2015.01.014DOI Listing
May 2015

Single-institution experience in the treatment of primary mediastinal B cell lymphoma treated with immunochemotherapy in the setting of response assessment by 18fluorodeoxyglucose positron emission tomography.

Authors:
Chelsea C Pinnix Bouthaina Dabaja Mohamed Amin Ahmed Hubert H Chuang Colleen Costelloe Christine F Wogan Valerie Reed Jorge E Romaguera Sattva Neelapu Yasuhiro Oki M Alma Rodriguez Luis Fayad Frederick B Hagemeister Loretta Nastoupil Francesco Turturro Nathan Fowler Michelle A Fanale Yago Nieto Issa F Khouri Sairah Ahmed L Jeffrey Medeiros Richard Eric Davis Jason Westin

Int J Radiat Oncol Biol Phys 2015 May;92(1):113-21

Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2015.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418191PMC
May 2015

Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma.

Authors:
Chelsea C Pinnix Grace L Smith Sarah Milgrom Eleanor M Osborne Jay P Reddy Mani Akhtari Valerie Reed Isidora Arzu Pamela K Allen Christine F Wogan Michele A Fanale Yasuhiro Oki Francesco Turturro Jorge Romaguera Luis Fayad Nathan Fowler Jason Westin Loretta Nastoupil Fredrick B Hagemeister M Alma Rodriguez Sairah Ahmed Yago Nieto Bouthaina Dabaja

Int J Radiat Oncol Biol Phys 2015 May;92(1):175-82

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.ijrobp.2015.02.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418193PMC
May 2015

A clinician's guide to double hit lymphomas.

Authors:
Chan Yoon Cheah Yasuhiro Oki Jason R Westin Francesco Turturro

Br J Haematol 2015 Mar 22;168(6):784-95. Epub 2014 Dec 22.

Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.13276DOI Listing
March 2015

A single case of rosai-dorfman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine.

Authors:
Koji Sasaki Naveen Pemmaraju Jason R Westin Wei-Lien Wang Joseph D Khoury Donald A Podoloff Bryan Moon Naval Daver Gautam Borthakur

Front Oncol 2014 29;4:297. Epub 2014 Oct 29.

Department of Leukemia, The University of Texas MD Anderson Cancer Center , Houston, TX , USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3389/fonc.2014.00297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212618PMC
November 2014

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.

Authors:
Nathan H Fowler R Eric Davis Seema Rawal Loretta Nastoupil Fredrick B Hagemeister Peter McLaughlin Larry W Kwak Jorge E Romaguera Michelle A Fanale Luis E Fayad Jason R Westin Jatin Shah Robert Z Orlowski Michael Wang Francesco Turturro Yasuhiro Oki Linda C Claret Lei Feng Veerabhadran Baladandayuthapani Tariq Muzzafar Kenneth Y Tsai Felipe Samaniego Sattva S Neelapu

Lancet Oncol 2014 Nov 15;15(12):1311-8. Epub 2014 Oct 15.

Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(14)70455-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370362PMC
November 2014

Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma.

Authors:
Jason R Westin

Clin Lymphoma Myeloma Leuk 2014 Oct 7;14(5):335-42. Epub 2014 Feb 7.

Division of Cancer Medicine, Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2014.01.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125533PMC
October 2014

Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma.

Authors:
Jason R Westin Peter McLaughlin Jorge Romaguera Fredrick B Hagemeister Barbara Pro Nam H Dang Felipe Samaniego Maria A Rodriguez Luis Fayad Yasuhiro Oki Michelle Fanale Nathan Fowler Loretta Nastoupil Lei Feng Evelyn Loyer Anas Younes

Br J Haematol 2014 Oct 8;167(2):177-84. Epub 2014 Jul 8.

Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.13014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279071PMC
October 2014

Double hit lymphoma: the MD Anderson Cancer Center clinical experience.

Authors:
Yasuhiro Oki Mansoor Noorani Pei Lin Richard E Davis Sattva S Neelapu Long Ma Mohamed Ahmed Maria Alma Rodriguez Fredrick B Hagemeister Nathan Fowler Michael Wang Michelle A Fanale Loretta Nastoupil Felipe Samaniego Hun J Lee Bouthaina S Dabaja Chelsea C Pinnix Leonard J Medeiros Yago Nieto Issa Khouri Larry W Kwak Francesco Turturro Jorge E Romaguera Luis E Fayad Jason R Westin

Br J Haematol 2014 Sep 18;166(6):891-901. Epub 2014 Jun 18.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.12982DOI Listing
September 2014

Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.

Authors:
Anas Younes Catherine Thieblemont Franck Morschhauser Ian Flinn Jonathan W Friedberg Sandy Amorim Benedicte Hivert Jason Westin Jessica Vermeulen Nibedita Bandyopadhyay Ronald de Vries Sriram Balasubramanian Peter Hellemans Johan W Smit Nele Fourneau Yasuhiro Oki

Lancet Oncol 2014 Aug 17;15(9):1019-26. Epub 2014 Jul 17.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(14)70311-0DOI Listing
August 2014

Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et al.

Authors:
Jason Westin Yasuhiro Oki Luis Fayad

Br J Haematol 2014 Apr 16;165(1):146-7. Epub 2013 Dec 16.

Department of Lymphoma and Myeloma, University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.12704DOI Listing
April 2014

Accelerated therapeutic progress in diffuse large B cell lymphoma.

Authors:
Qingqing Cai Jason Westin Kai Fu Madhav Desai Liang Zhang Huiqiang Huang Wenqi Jiang Rong Liang Zhengzi Qian Richard E Champlin Michael Wang

Ann Hematol 2014 Apr 28;93(4):541-56. Epub 2013 Dec 28.

Department of Medical Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, China.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s00277-013-1979-7DOI Listing
April 2014

Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial.

Authors:
Jason R Westin Fuliang Chu Min Zhang Luis E Fayad Larry W Kwak Nathan Fowler Jorge Romaguera Fredrick Hagemeister Michelle Fanale Felipe Samaniego Lei Feng Veerabhadran Baladandayuthapani Zhiqiang Wang Wencai Ma Yanli Gao Michael Wallace Luis M Vence Laszlo Radvanyi Tariq Muzzafar Rinat Rotem-Yehudar R Eric Davis Sattva S Neelapu

Lancet Oncol 2014 Jan 11;15(1):69-77. Epub 2013 Dec 11.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/S1470-2045(13)70551-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922714PMC
January 2014

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma.

Authors:
Bouthaina S Dabaja Jack Phan Osama Mawlawi L Jeffrey Medeiros Carol Etzel Fu-Wen Liang Donald Podoloff Yasuhiro Oki Fredrick B Hagemeister Hubert Chuang Luis E Fayad Jason Robert Westin Ferial Shihadeh Pamela K Allen Christine F Wogan Maria A Rodriguez

Leuk Lymphoma 2013 Dec 7;54(12):2631-8. Epub 2013 May 7.

Department of Radiation Oncology.

View Article

Download full-text PDF

 Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2013.78
Publisher Site
http://dx.doi.org/10.3109/10428194.2013.784967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827734PMC
December 2013

Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse large B-cell lymphoma.

Authors:
Yasuhiro Oki Jason R Westin Francisco Vega Hubert Chuang Nathan Fowler Sattva Neelapu Fredrick B Hagemeister Peter McLaughlin Larry W Kwak Jorge E Romaguera Michelle Fanale Anas Younes Maria Alma Rodriguez Robert Z Orlowski Michael Wang Souzanne T Ouzounian Felipe Samaniego Luis Fayad

Br J Haematol 2013 Dec 1;163(5):611-20. Epub 2013 Oct 1.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1111/bjh.12585DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278952PMC
December 2013

R-CHOP every 21 days for diffuse large B-cell lymphoma: still the standard of care?

Authors:
Jason Westin Fredrick Hagemeister

J Comp Eff Res 2013 Nov;2(6):537-40

MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.2217/cer.13.76DOI Listing
November 2013

Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.

Authors:
Jason R Westin Michael A Thompson Vince D Cataldo Luis E Fayad Nathan Fowler Michelle A Fanale Saatva Neelapu Felipe Samaniego Jorge Romaguera Jatin Shah Peter McLaughlin Barbara Pro Larry W Kwak Perpetua Sanjorjo William A Murphy Camillo Jimenez Bela Toth Wenli Dong Fredrick B Hagemeister

Clin Lymphoma Myeloma Leuk 2013 Apr 29;13(2):99-105. Epub 2012 Dec 29.

Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1016/j.clml.2012.11.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881262PMC
April 2013

It's about time: lessons for solid tumors from chronic myelogenous leukemia therapy.

Authors:
Jason R Westin Razelle Kurzrock

Mol Cancer Ther 2012 Dec 30;11(12):2549-55. Epub 2012 Nov 30.

Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston TX 77030, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1158/1535-7163.MCT-12-0473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107422PMC
December 2012

Therapy of newly diagnosed follicular lymphoma.

Authors:
Jason R Westin Sattva S Neelapu

Front Oncol 2012 11;2:188. Epub 2012 Dec 11.

University of Texas MD Anderson Cancer Center Houston, TX, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3389/fonc.2012.00188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518764PMC
December 2012

Hodgkin lymphoma untreated for six years presenting with tracheoesophageal fistula.

Authors:
Jason R Westin Amye Gibbs Keith R Mills Sattva S Neelapu

Case Rep Med 2012 2;2012:457908. Epub 2012 Jul 2.

Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

 Source
http://www.hindawi.com/journals/crim/2012/457908/
Publisher Site
http://dx.doi.org/10.1155/2012/457908DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395413PMC
August 2012

Steroid-Refractory Acute GVHD: Predictors and Outcomes.

Authors:
Jason R Westin Rima M Saliba Marcos De Lima Amin Alousi Chitra Hosing Muzaffar H Qazilbash Issa F Khouri Elizabeth J Shpall Paolo Anderlini Gabriela Rondon Borje S Andersson Richard Champlin Daniel R Couriel

Adv Hematol 2011 3;2011:601953. Epub 2011 Nov 3.

Stem Cell Transplantation & Cellular Therapy, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1155/2011/601953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3216266PMC
November 2011

Vive la résistance: stem cells in mantle cell lymphoma.

Authors:
R Eric Davis Jason R Westin

Leuk Lymphoma 2011 Jun 4;52(6):944-5. Epub 2011 Apr 4.

Department of Lymphoma and Myeloma, University of Texas M D Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/10428194.2011.569622DOI Listing
June 2011

De novo CD5+ diffuse large B-cell lymphoma: a distinct subset with adverse features, poor failure-free survival and outcome with conventional therapy.

Authors:
Jason Westin Peter McLaughlin

Leuk Lymphoma 2010 Jan;51(1):161-3

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.3109/10428190903324244DOI Listing
January 2010

Beyond R-CHOP and the IPI in large-cell lymphoma: molecular markers as an opportunity for stratification.

Authors:
Jason R Westin Luis E Fayad

Curr Hematol Malig Rep 2009 Oct;4(4):218-24

Department of Lymphoma/Myeloma, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit #429, Houston, TX 77030, USA.

View Article

Download full-text PDF

 Source
http://dx.doi.org/10.1007/s11899-009-0029-yDOI Listing
October 2009